Anderson Mori & Tomotsune has a long history of advising international and Japanese health care and life sciences clients in the IP context. We also provide advice in other substantive legal areas, including pharmaceutical regulations (e.g., the Pharmaceutical Affairs Act and the Chemical Substances Act), antitrust and corporate laws. In particular, we advise our health care and life sciences clients on patent infringement litigation, invalidity actions, revocation actions and related matters. We consult with our clients on a constant basis and continually conduct research on critical issues. We also conduct due diligence investigations both as part of stand alone health care and life sciences transactions and as part of larger M&A transactions. Our health care and life sciences attorneys are engaged in proactively assisting clients in the drafting and negotiation of contracts, taking into consideration the uniqueness of the health care and life sciences industries and the nuances of Japanese practice.